Postpartum Sexual Function in Pregnant Women With COVID-19

Official Title

Evaluation of Pregnant Women Diagnosed With COVID-19 Using Carol Postpartum Sexual Function and Dyspareunia Scale

Brief Summary

The aim of this study is to identify women with postpartum sexual dysfunction and dyspareunia risk in the early period and to use the treatment and care services they need effectively. Our secondary aim is to reveal the difference in sexual life in the postpartum period between healthy pregnant women and pregnant women diagnosed with COVID-19.

Status

Completed

Conditions

COVID-19

Dyspareunia

Postpartum Period

Eligibility Criteria

Inclusion Criteria:

- Pregnant Patient with COVID-19

Exclusion Criteria:

- Those with known sexual dysfunction disorder

Eligibility Gender

Female

Eligibility Age

Minimum: 18 Years ~ Maximum: 45 Years

Countries

Turkey

Locations

Kanuni Sultan Suleyman Training and Research Hospital
Istanbul, Halkali, Turkey

NCT Number

NCT04389489

Keywords

Postpartum Period

Dyspareunia

Covid-19

MeSH Terms

COVID-19

Dyspareunia

Disclaimer:

Expanded Access program information for companies listed in the Expanded Access Company Directory is pulled daily from ClinicalTrials.gov, a resource provided by the National Institutes of Health in cooperation with the U.S. Food and Drug Administration. Click here for more information about ClinicalTrials.gov.

(202) 849 - 2075

1333 New Hampshire Ave, NW
Suite 420
Washington, DC 20036

admin@reaganudall.org

Kanuni Sultan Suleyman Training and Research Hospital

Postpartum Sexual Function in Pregnant Women With COVID-19

Disclaimer:

Subscribe for updates from the Reagan-Udall Foundation for the FDA